• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群研究的双膦酸盐相关颌骨坏死当前算法的不确定性:一项系统评价

Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: a systematic review.

作者信息

Kim Hye-Yeon, Kim Jin-Woo, Kim Sun-Jong, Lee Sang-Hwa, Lee Hong-Soo

机构信息

Department of Family Medicine, Graduate School of Medicine, Ewha Womans University, Seoul, Korea.

Research Institute for Intractable Osteonecrosis of the Jaw, School of Medicine, Ewha Womans University, Seoul, Korea.

出版信息

J Bone Miner Res. 2017 Mar;32(3):584-591. doi: 10.1002/jbmr.3017. Epub 2017 Jan 30.

DOI:10.1002/jbmr.3017
PMID:27736017
Abstract

To assess the relevance of previous epidemiologic studies on bisphosphonate-related osteonecrosis of the jaw (BRONJ), we first conducted a systematic review of large population-based observational studies and evaluated the validity of claims-based algorithms for the identification of BRONJ. Studies containing primary observational epidemiologic data regarding bisphosphonate (BP) exposure and outcomes of osteonecrosis of the jaw were systematically reviewed. Using surrogates for identifying potential BRONJ cases from a population-based hospital registry, validation was performed through medical chart review. Positive predictive value (PPV) was estimated for each diagnostic code and for the overall algorithm utilized. Various strategies to increase PPV were also performed. Seventeen studies were systematically reviewed and presented with variations in study quality as well as inconsistent findings. Moreover, there was a high level of methodological heterogeneity. A total of 1920 patients were identified through the ICD-10 algorithm with potential BRONJ, although only 109 cases were confirmed, corresponding to an overall PPV of 5.68% (95% confidence interval [CI] 4.68-6.81). Only K10.2 (inflammatory conditions of the jaw) exhibited a relatively high PPV of 26.18%, which increased to 74.47% after confinement to BP users. Other strategies to increase PPV value were not effective. Our findings showed that the overall PPV for BRONJ identification was very low, indicating low validity of the current algorithm and possible overestimation of ONJ occurrence. There is an urgent need to develop more reliable and specific operational definitions for the identification of BRONJ cases in large population databases. © 2016 American Society for Bone and Mineral Research.

摘要

为评估既往关于双膦酸盐相关颌骨坏死(BRONJ)的流行病学研究的相关性,我们首先对基于大人群的观察性研究进行了系统评价,并评估了基于索赔的算法用于识别BRONJ的有效性。对包含双膦酸盐(BP)暴露及颌骨坏死结局的原始观察性流行病学数据的研究进行了系统评价。使用替代指标从基于人群的医院登记处识别潜在的BRONJ病例,并通过病历审查进行验证。对每个诊断代码及所使用的总体算法估计阳性预测值(PPV)。还实施了各种提高PPV的策略。对17项研究进行了系统评价,这些研究在研究质量上存在差异且结果不一致。此外,方法学异质性程度较高。通过ICD - 10算法识别出1920例有潜在BRONJ的患者,但仅确诊109例,总体PPV为5.68%(95%置信区间[CI] 4.68 - 6.81)。只有K10.2(颌骨炎症性疾病)表现出相对较高的PPV,为26.18%,在仅限于BP使用者后增至74.47%。其他提高PPV值的策略均无效。我们的研究结果表明,用于识别BRONJ的总体PPV非常低,表明当前算法的有效性较低,且可能高估了ONJ的发生率。迫切需要制定更可靠、更具体的操作定义,以在大型人群数据库中识别BRONJ病例。© 2016美国骨与矿物质研究学会

相似文献

1
Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: a systematic review.基于人群研究的双膦酸盐相关颌骨坏死当前算法的不确定性:一项系统评价
J Bone Miner Res. 2017 Mar;32(3):584-591. doi: 10.1002/jbmr.3017. Epub 2017 Jan 30.
2
Bisphosphonates in multiple myeloma: an updated network meta-analysis.双膦酸盐类药物在多发性骨髓瘤中的应用:一项更新的网状Meta分析
Cochrane Database Syst Rev. 2017 Dec 18;12(12):CD003188. doi: 10.1002/14651858.CD003188.pub4.
3
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Bisphosphonates and other bone agents for breast cancer.用于乳腺癌的双膦酸盐及其他骨治疗药物。
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD003474. doi: 10.1002/14651858.CD003474.pub4.
6
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
7
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

引用本文的文献

1
Time since last intravenous bisphosphonate and risk of osteonecrosis of the jaw in osteoporotic patients.骨质疏松症患者上次静脉注射双膦酸盐后的时间与颌骨坏死风险
Nat Commun. 2025 May 11;16(1):4367. doi: 10.1038/s41467-025-59718-x.
2
Therapeutic approaches for SAPHO syndrome from the perspective of pathogenesis: a review of the literature.从发病机制角度看SAPHO综合征的治疗方法:文献综述
Front Immunol. 2025 Apr 15;16:1560398. doi: 10.3389/fimmu.2025.1560398. eCollection 2025.
3
No increased risk of osteonecrosis of the jaw in osteoporotic patients with dental implants: a nationwide cohort study.
种植牙骨质疏松患者颌骨坏死风险未增加:一项全国性队列研究。
Clin Oral Investig. 2024 Jan 9;28(1):83. doi: 10.1007/s00784-023-05483-4.
4
Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations.药物相关性颌骨坏死临床试验报告规范:综述与建议。
Cells. 2022 Dec 16;11(24):4097. doi: 10.3390/cells11244097.
5
Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium.癌症患者的药物相关性颌骨坏死:来自 OneFlorida 临床研究联盟的结果。
J Bone Miner Res. 2022 Dec;37(12):2466-2471. doi: 10.1002/jbmr.4708. Epub 2022 Oct 5.
6
Gradual, but Not Sudden, Dose-Dependent Increase of ONJ Risk With Bisphosphonate Exposure: A Nationwide Cohort Study in Women With Osteoporosis.随着双膦酸盐暴露,颌骨坏死风险逐渐增加,但无骤增:一项针对骨质疏松症女性的全国性队列研究。
Front Endocrinol (Lausanne). 2021 Dec 9;12:774820. doi: 10.3389/fendo.2021.774820. eCollection 2021.
7
Assessment of a Claims-Based ICD-9 and ICD-10 Medication-Related Osteonecrosis of the Jaw Algorithm in the United States.美国基于索赔的ICD - 9和ICD - 10颌骨药物相关性骨坏死算法评估
Clin Epidemiol. 2021 Oct 28;13:1019-1026. doi: 10.2147/CLEP.S325080. eCollection 2021.
8
Validity of diagnoses and procedures in Japanese dental claims data.日本牙科理赔数据中诊断和程序的有效性。
BMC Health Serv Res. 2021 Oct 18;21(1):1116. doi: 10.1186/s12913-021-07135-3.
9
Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review.药物相关性颌骨坏死:一项批判性叙述性综述
J Clin Med. 2021 Sep 24;10(19):4367. doi: 10.3390/jcm10194367.
10
Panoramic radiographic features that predict the development of bisphosphonate-related osteonecrosis of the jaw.全景 X 线片特征预测双膦酸盐相关性颌骨骨坏死的发生。
Oral Radiol. 2018 May;34(2):151-160. doi: 10.1007/s11282-017-0293-9. Epub 2017 Jun 12.